{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:34:48Z","timestamp":1786984488364,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011029","name":"Helmholtz-Alberta Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.antiviral.2020.104774","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:53:25Z","timestamp":1584492805000},"page":"104774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry"],"prefix":"10.1016","volume":"177","author":[{"given":"Sebastian","family":"Blockus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja M.","family":"Sake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wetzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Grethe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Graalmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Pils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Le Goffic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Galloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Prochnow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Rox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"H\u00fcttel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeljka","family":"Rupcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Wiegmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Dijkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Rameix-Welti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"El\u00e9ou\u00ebt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Paul","family":"Duprex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesine","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Br\u00f6nstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Haid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pietschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104774_bib1","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s00705-016-2880-1","article-title":"Taxonomy of the order Mononegavirales: update 2016","volume":"161","author":"Afonso","year":"2016","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2020.104774_bib2","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/infdis\/151.4.626","article-title":"Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies","volume":"151","author":"Anderson","year":"1985","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104774_bib3","doi-asserted-by":"crossref","first-page":"25806","DOI":"10.1038\/srep25806","article-title":"Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication","volume":"6","author":"Bailly","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104774_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nchembio.1982","article-title":"Molecular mechanism of respiratory syncytial virus fusion inhibitors","volume":"12","author":"Battles","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.antiviral.2020.104774_bib5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00018-018-2992-8","article-title":"Mechanisms protecting host cells against bacterial pore-forming toxins","volume":"76","author":"Brito","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.antiviral.2020.104774_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/AAC.48.2.413-422.2004","article-title":"Orally active fusion inhibitor of respiratory syncytial virus","volume":"48","author":"Cianci","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104774_bib7","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/acs.jmedchem.8b01361","article-title":"State of the art in respiratory syncytial virus drug discovery and development","volume":"62","author":"Cockerill","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104774_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1073\/pnas.93.1.81","article-title":"Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus","volume":"93","author":"Collins","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104774_bib9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1401184","article-title":"Oral GS-5806 activity in a respiratory syncytial virus challenge study","volume":"371","author":"DeVincenzo","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104774_bib10","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104774_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064010","article-title":"The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications","volume":"8","author":"Ferir","year":"2013","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.antiviral.2020.104774_bib12","doi-asserted-by":"crossref","first-page":"e02241","DOI":"10.1128\/AAC.02241-16","article-title":"A short double-stapled peptide inhibits respiratory syncytial virus entry and spreading","volume":"61","author":"Gaillard","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104774_bib13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.antiviral.2010.12.005","article-title":"Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity","volume":"89","author":"Gentzsch","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104774_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/CMR.00010-16","article-title":"Respiratory syncytial virus: infection, detection, and new options for prevention and treatment","volume":"30","author":"Griffiths","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2020.104774_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jcv.2004.11.025","article-title":"Real-time RT-PCR detection of 12 respiratory viral infections in four triplex reactions","volume":"33","author":"Gunson","year":"2005","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2020.104774_bib16","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1128\/JVI.03074-15","article-title":"Identification of a human respiratory syncytial virus cell entry inhibitor by using a novel lentiviral pseudotype system","volume":"90","author":"Haid","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104774_bib17","doi-asserted-by":"crossref","first-page":"24231","DOI":"10.1074\/jbc.M111.253393","article-title":"Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities","volume":"286","author":"Henriques","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104774_bib18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV study group","volume":"102","author":"IMpact","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.antiviral.2020.104774_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4939-2438-7_8","article-title":"Characterization of human coronaviruses on well-differentiated human airway epithelial cell cultures","volume":"1282","author":"Jonsdottir","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2020.104774_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/viro.2001.0903","article-title":"Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells","volume":"284","author":"Kalajzic","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104774_bib21","doi-asserted-by":"crossref","first-page":"11684","DOI":"10.1021\/bi000471y","article-title":"Heptad-repeat regions of respiratory syncytial virus F1 protein form a six-membered coiled-coil complex","volume":"39","author":"Lawless-Delmedico","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2020.104774_bib22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00006454-200207000-00005","article-title":"Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999","volume":"21","author":"Leader","year":"2002","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2020.104774_bib23","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1128\/JVI.03587-14","article-title":"Recombinant subgroup B human respiratory syncytial virus expressing enhanced green fluorescent protein efficiently replicates in primary human cells and is virulent in cotton rats","volume":"89","author":"Lemon","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104774_bib24","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/S0140-6736(16)31593-8","article-title":"Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the sustainable development goals","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2020.104774_bib25","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0264-410X(99)00373-4","article-title":"Liposome encapsulation of a soluble recombinant fragment of the respiratory syncytial virus (RSV) G protein enhances immune protection and reduces lung eosinophilia associated with virus challenge","volume":"18","author":"Mader","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2020.104774_bib26","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S2213-2600(15)00255-6","article-title":"Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics","volume":"3","author":"Mazur","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.antiviral.2020.104774_bib27","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/anie.200905773","article-title":"Labyrinthopeptins: a new class of carbacyclic lantibiotics","volume":"49","author":"Meindl","year":"2010","journal-title":"Angew. Chem."},{"key":"10.1016\/j.antiviral.2020.104774_bib28","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/anie.200905909","article-title":"In vitro biosynthesis of the prepeptide of type-III lantibiotic labyrinthopeptin A2 including formation of a C-C bond as a post-translational modification","volume":"49","author":"Muller","year":"2010","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.antiviral.2020.104774_bib29","doi-asserted-by":"crossref","first-page":"ofy031","DOI":"10.1093\/ofid\/ofy031","article-title":"Palivizumab prophylaxis for respiratory syncytial virus: examining the evidence around value","volume":"5","author":"Olchanski","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104774_bib30","doi-asserted-by":"crossref","first-page":"11129","DOI":"10.1128\/JVI.01612-15","article-title":"A druggable pocket at the nucleocapsid\/phosphoprotein interaction site of human respiratory syncytial virus","volume":"89","author":"Ouizougun-Oubari","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104774_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0166-3542(90)90001-N","article-title":"A three-dimensional model to analyze drug-drug interactions","volume":"14","author":"Prichard","year":"1990","journal-title":"Antivir. Res."},{"issue":"4","key":"10.1016\/j.antiviral.2020.104774_bib32","first-page":"e01471","article-title":"Labyrinthopeptins exert broad-spectrum antiviral activity through lipid-binding-mediated virolysis","volume":"92","author":"Prochnow","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104774_bib33","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1038\/ncomms6104","article-title":"Visualizing the replication of respiratory syncytial virus in cells and in living mice","volume":"5","author":"Rameix-Welti","year":"2014","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104774_bib34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/bioengineering5020042","article-title":"Large scale production and downstream processing of labyrinthopeptins from the actinobacterium Actinomadura namibiensis","volume":"5","author":"Rupcic","year":"2018","journal-title":"Bioengineering"},{"key":"10.1016\/j.antiviral.2020.104774_bib35","article-title":"Global disease burden estimates of respiratory syncytial virus-associated acute respiratory infection in older adults in 2015: a systematic review and meta-analysis","author":"Shi","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104774_bib36","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2020.104774_bib37","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S1473-3099(14)70990-9","article-title":"Global, regional, and national estimates of pneumonia burden in HIV-infected children in 2010: a meta-analysis and modelling study","volume":"14","author":"Theodoratou","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104774_bib38","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1073\/pnas.1110203109","article-title":"In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo","volume":"109","author":"Villenave","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104774_bib39","doi-asserted-by":"crossref","first-page":"E3441","DOI":"10.1073\/pnas.1405198111","article-title":"Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors","volume":"111","author":"Yan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104774_bib40","doi-asserted-by":"crossref","first-page":"11651","DOI":"10.1128\/JVI.01387-06","article-title":"In vitro and in vivo fitness of respiratory syncytial virus monoclonal antibody escape mutants","volume":"80","author":"Zhao","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104774_bib41","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/infdis\/jiq100","article-title":"Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and\/or motavizumab","volume":"203","author":"Zhu","year":"2011","journal-title":"J. Infect. Dis."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421930614X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421930614X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:31:30Z","timestamp":1759062690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421930614X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":41,"alternative-id":["S016635421930614X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104774","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104774"}}